This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Laboratorios Salvat, S.a.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Anna Fernández Serrat: Innovator in PPAR-γ Modulators
Introduction
Anna Fernández Serrat is a prominent inventor based in Cagnes sur Mer, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that act as PPAR-γ modulators. Her innovative work is aimed at addressing various medical conditions mediated by these receptors.
Latest Patents
Anna holds a patent for "Tyrosine derivatives as PPAR-γ-modulators." This patent includes compounds of general formula I, along with their salts and solvates. The compounds feature specific radicals, such as 2-benzoylphenylamino, and are designed to be effective in the treatment or prevention of conditions associated with PPAR-γ receptors. She has 1 patent to her name, showcasing her expertise in this specialized area.
Career Highlights
Anna is currently associated with Laboratorios Salvat, S.A., where she continues to push the boundaries of pharmaceutical innovation. Her work has been instrumental in advancing the understanding and application of PPAR-γ modulators in medical treatments.
Collaborations
Throughout her career, Anna has collaborated with notable colleagues, including Carmen Serra Comas and Dolors Balsa López. These partnerships have enriched her research and contributed to the success of her projects.
Conclusion
Anna Fernández Serrat is a trailblazer in the field of pharmaceutical innovation, particularly in the development of PPAR-γ modulators. Her contributions are vital for advancing medical treatments and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile